AVADEL PHARMACEUTICALS PLC (NASDAQ:AVDL) Files An 8-K Regulation FD Disclosure
Item 7.01.

AVADEL PHARMACEUTICALS PLC Exhibit
EX-99.1 2 tm1926283d1_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1       Avadel Pharmaceuticals Receives U.S. FDA Approval for NouressTM (AV001),…
To view the full exhibit click here